Bill Gates, the American computer entrepreneur and famous founder of Microsoft, decided to finance the Italian Rei vaccinettime. In fact, the Bill & Melinda Gates Foundation (Bmgf) has allocated a loan of 1,4 million dollars for the development of new vaccines based on the proprietary Grad platform of the Italian biotech company Reithera Srl.
Bill Gates finances Reithera
“The funded program will focus on two key objectives - explains Reithera - Develop second generation vaccines that can provide broader coverage against Sars-CoV-2 variants. Variants of great concern. It is also intended to support the HIV initiative of the Bill & Melinda Gates Foundation for the generation of innovative vaccines ".
Reithera is keen to point out that it will exploit the capabilities of Grad adenoviral vector technology. The aim is to induce a robust cell-mediated immune response against the infectious agent. The project is designed so that mainly low- and middle-income countries, especially Africa, benefit from the results. That is, countries that are most affected by HIV and currently have very limited access to vaccines against Covid-19.
Vaccines for the new variants of Covid
“We are thrilled - says Stefano Colloca, chief Technology Officer and co-founder of Reithera - that the prestigious Bill & Melinda Gates Foundation has decided to invest in tech of our company. The project will allow us to access their network of highly experienced scientific collaborators.
In this regard, we will exploit the potential of our new Grad vector technology for the development of necessary vaccines, both for the new variants of Covid-19 and for HIV. The hope is that the new production of vaccines can have a very positive impact on the lives of people in the poorest countries in the world ”.
(On the cover Bill Gates - photo Wikimedia Commons - Energy.Gov)
